Cryocell International Stock Performance
| CCEL Stock | USD 3.43 0.06 1.78% |
The firm shows a Beta (market volatility) of 0.14, which signifies not very significant fluctuations relative to the market. As returns on the market increase, CryoCell International's returns are expected to increase less than the market. However, during the bear market, the loss of holding CryoCell International is expected to be smaller as well. At this point, CryoCell International has a negative expected return of -0.22%. Please make sure to confirm CryoCell International's value at risk, accumulation distribution, as well as the relationship between the Accumulation Distribution and day typical price , to decide if CryoCell International performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days CryoCell International has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain quite persistent which may send shares a bit higher in March 2026. The latest mess may also be a sign of long-standing up-swing for the company institutional investors. ...more
Actual Historical Performance (%)
One Day Return 1.69 | Five Day Return (0.38) | Year To Date Return (0.09) | Ten Year Return 16.17 | All Time Return (31.46) |
Forward Dividend Yield 0.178 | Payout Ratio | Forward Dividend Rate 0.6 | Dividend Date 2025-05-30 | Ex Dividend Date 2025-05-21 |
1 | Acquisition by David Portnoy of 1921 shares of CryoCell International at 4.08 subject to Rule 16b-3 | 11/19/2025 |
2 | Acquisition by David Portnoy of 289 shares of CryoCell International at 4.0 subject to Rule 16b-3 | 11/20/2025 |
3 | Why Cryo Cell International Inc. stock signals breakout potential - July 2025 Reactions Stock Market Timing Techniques - B NI V | 11/26/2025 |
4 | Cryo-Cell International Amends Credit Agreement with Susser Bank - MSN | 12/09/2025 |
5 | Can Cryo Cell International Inc stock deliver double digit returns - July 2025 Highlights Reliable Volume Spike Alerts - moha.gov.vn | 12/30/2025 |
6 | Acquisition by Jill Taymans of 10000 shares of CryoCell International at 3.54 subject to Rule 16b-3 | 01/07/2026 |
7 | Resistance Check What dividend growth rate does Cryo Cell International Inc. offer - 2025 Valuation Update Weekly High Conviction Ideas - baoquankhu1.vn | 01/20/2026 |
8 | Is Cryo Cell International Inc. stock forming a triangle pattern - Breakout Watch Smart Money Movement Tracker - mfd.ru | 02/12/2026 |
| Begin Period Cash Flow | 406.1 K | |
| Total Cashflows From Investing Activities | -4.9 M |
CryoCell International Relative Risk vs. Return Landscape
If you would invest 406.00 in CryoCell International on November 16, 2025 and sell it today you would lose (63.00) from holding CryoCell International or give up 15.52% of portfolio value over 90 days. CryoCell International is currently does not generate positive expected returns and assumes 3.1093% risk (volatility on return distribution) over the 90 days horizon. In different words, 27% of stocks are less volatile than CryoCell, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
CryoCell International Target Price Odds to finish over Current Price
The tendency of CryoCell Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 3.43 | 90 days | 3.43 | about 79.17 |
Based on a normal probability distribution, the odds of CryoCell International to move above the current price in 90 days from now is about 79.17 (This CryoCell International probability density function shows the probability of CryoCell Stock to fall within a particular range of prices over 90 days) .
CryoCell International Price Density |
| Price |
Predictive Modules for CryoCell International
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as CryoCell International. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of CryoCell International's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
CryoCell International Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. CryoCell International is not an exception. The market had few large corrections towards the CryoCell International's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold CryoCell International, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of CryoCell International within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.3 | |
β | Beta against Dow Jones | 0.14 | |
σ | Overall volatility | 0.32 | |
Ir | Information ratio | -0.11 |
CryoCell International Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of CryoCell International for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for CryoCell International can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| CryoCell International generated a negative expected return over the last 90 days | |
| CryoCell International has high historical volatility and very poor performance | |
| CryoCell International currently holds 12.93 M in liabilities with Debt to Equity (D/E) ratio of 0.26, which may suggest the company is not taking enough advantage from borrowing. CryoCell International has a current ratio of 0.46, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about CryoCell International's use of debt, we should always consider it together with its cash and equity. | |
| About 42.0% of CryoCell International shares are held by company insiders | |
| Latest headline from news.google.com: Is Cryo Cell International Inc. stock forming a triangle pattern - Breakout Watch Smart Money Movement Tracker - mfd.ru |
CryoCell International Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of CryoCell Stock often depends not only on the future outlook of the current and potential CryoCell International's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. CryoCell International's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 8.2 M | |
| Cash And Short Term Investments | 3.5 M |
CryoCell International Fundamentals Growth
CryoCell Stock prices reflect investors' perceptions of the future prospects and financial health of CryoCell International, and CryoCell International fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CryoCell Stock performance.
| Return On Equity | 1.29 | ||||
| Return On Asset | 0.0429 | ||||
| Profit Margin | (0.01) % | ||||
| Operating Margin | 0.24 % | ||||
| Current Valuation | 36.52 M | ||||
| Shares Outstanding | 8.06 M | ||||
| Price To Earning | 10.76 X | ||||
| Price To Book | 9.72 X | ||||
| Price To Sales | 0.87 X | ||||
| Revenue | 31.99 M | ||||
| Gross Profit | 24.47 M | ||||
| EBITDA | 1.42 M | ||||
| Net Income | 402.1 K | ||||
| Cash And Equivalents | 2.96 M | ||||
| Cash Per Share | 0.35 X | ||||
| Total Debt | 12.93 M | ||||
| Debt To Equity | 0.26 % | ||||
| Current Ratio | 0.47 X | ||||
| Book Value Per Share | (1.84) X | ||||
| Cash Flow From Operations | 6.01 M | ||||
| Earnings Per Share | (0.06) X | ||||
| Market Capitalization | 27.61 M | ||||
| Total Asset | 64.68 M | ||||
| Retained Earnings | (32.78 M) | ||||
| Working Capital | (9.04 M) | ||||
| Current Asset | 6.08 M | ||||
| Current Liabilities | 2.82 M | ||||
About CryoCell International Performance
By examining CryoCell International's fundamental ratios, stakeholders can obtain critical insights into CryoCell International's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that CryoCell International is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 34.74 | 33.00 | |
| Return On Tangible Assets | 0.01 | 0.01 | |
| Return On Capital Employed | 0.07 | 0.08 | |
| Return On Assets | 0.01 | 0.01 | |
| Return On Equity | (0.04) | (0.04) |
Things to note about CryoCell International performance evaluation
Checking the ongoing alerts about CryoCell International for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for CryoCell International help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CryoCell International generated a negative expected return over the last 90 days | |
| CryoCell International has high historical volatility and very poor performance | |
| CryoCell International currently holds 12.93 M in liabilities with Debt to Equity (D/E) ratio of 0.26, which may suggest the company is not taking enough advantage from borrowing. CryoCell International has a current ratio of 0.46, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about CryoCell International's use of debt, we should always consider it together with its cash and equity. | |
| About 42.0% of CryoCell International shares are held by company insiders | |
| Latest headline from news.google.com: Is Cryo Cell International Inc. stock forming a triangle pattern - Breakout Watch Smart Money Movement Tracker - mfd.ru |
- Analyzing CryoCell International's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CryoCell International's stock is overvalued or undervalued compared to its peers.
- Examining CryoCell International's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CryoCell International's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CryoCell International's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CryoCell International's stock. These opinions can provide insight into CryoCell International's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CryoCell International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in discontinued. For more information on how to buy CryoCell Stock please use our How to buy in CryoCell Stock guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CryoCell International. Projected growth potential of CryoCell fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive CryoCell International assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth (0.31) | Dividend Share 0.65 | Earnings Share (0.06) | Revenue Per Share | Quarterly Revenue Growth (0.03) |
Investors evaluate CryoCell International using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating CryoCell International's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause CryoCell International's market price to deviate significantly from intrinsic value.
It's important to distinguish between CryoCell International's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CryoCell International should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, CryoCell International's market price signifies the transaction level at which participants voluntarily complete trades.